Michael Dell, MD
Michael S. Dell, MD, is a pediatrician at University Hospitals Rainbow Babies & Children’s Hospital and Professor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Dell is board certified in pediatrics. His special interest is general pediatrics.
He earned his undergraduate degree with honors from Swarthmore College, Swarthmore, Pa., where he was Phi Beta Kappa. He received his medical degree from Harvard Medical School, Boston, Mass. Dr. Dell completed a residency in pediatrics at Children’s Hospital of Philadelphia, Philadelphia, Pa., where he was Chief Resident in his final year of training.
He was appointed to the UH Rainbow Babies & Children's Hospital staff in 1998. Prior to that he was on the staff at St. Christopher’s Hospital for Children, Philadelphia, and Holy Redeemer Hospital and Medical Center, Meadowbrook, Pa., and Clinical Assistant Professor of Pediatrics, Medical College of Pennsylvania Hahnemann University School of Medicine, Philadelphia.
He has presented locally, nationally and internationally on medical student education and has published articles in professional journals related to this topic. Dr. Dell has received the Patients’ Choice Award every year since 2011 and has been selected as a Top Doc by Cleveland Magazine every year since 2002 and by Northern Ohio Live every year since 2004.
Honors and Recognition
Patients’ Choice Award since 2011
Top Doc Cleveland since 2002
- General Academic Pediatrics
- Medical Education
- Pediatrics - American Board of Pediatrics
Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - Children's Hospital Of Philadelphia (1995 - 1996)
Residency | Pediatrics
Pediatrics - Children's Hospital Of Philadelphia (1992 - 1995)
Harvard Medical School (1988 - 1992)
Swarthmore College (1987)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Michael Dell did not disclose any Outside Relationships with Industry.